[1] Akgül Ö, Kılıç G, Kılıç E, et al.A patient with ankylo-sing spondylitis who developed infliximab-induced lupus and treated with etanercept[J]. Rheumatol Int,2014, 34(3):443-444.
[2] Tang J, Zhang C, Shi W.A pedigree with systemic lupus erythematosus and ankylosing spondylitis[J]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi,2013,30(3):372.
[3] Kook MH, Yoo HG, Hong MJ, et al.Coexisting systemic lupus erythematosus and ankylosing spondylitis: a case report and review of the literature[J]. Lupus,2012,21(3):348-349.
[4] Mrabet D, Rekik S, Sahli H, et al.Ankylosing spondylitis in female systemic lupus erythematosus: a rare combination[J]. Lupus,2011,20(7):777-778.
[5] Singh S, Sonkar GK, Singh U.Coexistence of ankylosing spondylitis and systemic lupus erythematosus[J]. J Chin Med Assoc,2010,73(5):260-261.
[6] Jiang L, Dai X, Liu J, et al.Hypoparathyroidism in a patient with systemic lupus erythematosus coexisted with ankylosing spondylitis: a case report and review of literature[J]. Joint Bone Spine,2010,77(6):608-610.
[7] 王燕茹, 张育, 魏华, 等. 强直性脊柱炎合并系统性红斑狼疮一例并文献复习[J]. 中华临床医师杂志,2012,6(21):6902-6904.
[8] Sundquist K, Martineus JC, Li X, et al.Concordant and discordant associations between rheumatoid arthritis, systemic lupus erythematosus and ankylosing spondylitis based on all hospitalizations in Sweden between 1973 and 2004[J]. Rheumatology(Oxford),2008,47(8):1199-1202.
[9] Pérez-García C, Maymo J, Lisbona Pérez MP, et al.Drug-induced systemic lupus erythematosus in ankylosing spondylitis associated with infliximab[J]. Rheumatology (Oxford),2006,45(1):114-116.
[10] Marzano AV, Ramoni S, Del Papa N,et al.Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions[J]. Lupus,2008,17(4):329-331.
[11] Wendling D.IL-23 and IL-17 in ankylosing spondylitis[J]. Rheumatol Int,2010,30(11):1547.
[12] 沈思钰, 朱培元, 傅晓东. 系统性红斑狼疮与他汀类药物治疗的关系[J]. 内科理论与实践,2016,11(1):60-62.
[13] International Genetics of Ankylosing Spondylitis Consortium (IGAS)1, Cortes A, Hadler J, et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci[J]. Nat Genet,2013,45(7):730-738.
[14] Bowness P, Ridley A, Shaw J, et al.Th17 cells expressi-ng KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis[J]. J Immunol,2011,186(4):2672-2680.
[15] Li D, Guo B, Wu H, et al.Interleukin-17 in systemic lupus erythematosus: A comprehensive review[J]. Autoimmunity,2015,48(6):353-361.
[16] Zickert A, Amoudruz P, Sundström Y, et al.IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment[J]. BMC Immunol,2015,16:7.
[17] Wong CK, Lit LC, Tam LS, et al.Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity[J]. Clin Immunol,2008,127(3):385-393.
[18] Park SJ, Kim JH, Pai KS, et al.The link of HLA-B27 with interleukin-23/interleukin-17 axis in coexisting systemic lupus erythematosus and ankylosing spondylitis[J]. Lupus,2011,20(14):1566. |
